Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid Arthritis
Open Access
- 3 August 2010
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 37 (10), 2006-2013
- https://doi.org/10.3899/jrheum.100184
Abstract
Objective. Interleukin 33 (IL-33) is a novel cytokine involved in joint inflammation in animal models. We analyzed the expression of IL-33 in the serum and synovial fluid of patients with rheumatoid arthritis (RA) and investigated its possible pathophysiological importance. Methods. The concentration of IL-33 was measured by ELISA in the serum of 223 patients with RA and 159 controls. Anticyclic citrullinated peptide, rheumatoid factor (RF)-IgA, and RF-IgG were tested by ELISA. Antikeratin antibody and antiperinuclear factor were tested by indirect immunofluorescence assay. Erythrocyte sedimentation rate, C-reactive protein, and immunoglobulins were measured by standard laboratory techniques. The association of IL-33 level with clinical and serologic features of RA was analyzed. We tested the change of IL-33 level following tumor necrosis factor (TNF-α) blockade therapy in 40 patients with RA. Results. In contrast to almost no detectable IL-33 in osteoarthritis and healthy serum, IL-33 could be detected in 94 out of the 223 RA cases (42.2%). Serum IL-33 concentration was significantly higher in patients with RA than in control groups. The level of serum IL-33 decreased after anti-TNF treatment. The level of serum IL-33 was correlated with the production of IgM and RA-related autoantibodies including RF and anticitrullinated protein antibodies. However, no correlation was found between IL-33 concentration and acute-phase inflammation reactant or the score of the Disease Activity Index, suggesting a complex or indirect character of the link between IL-33 and the inflammation in RA. Conclusion. The level of IL-33 is abnormally elevated in RA serum. The elevation of serum IL-33 was at least partly attributed to excessive TNF-α in RA. IL-33 might be involved in the regulation of autoantibody production in RA.Keywords
This publication has 46 references indexed in Scilit:
- Evidence that cytokines play a role in rheumatoid arthritisJCI Insight, 2008
- Cytokines as Therapeutic Targets: Advances and LimitationsImmunity, 2008
- B cells in rheumatoid arthritisAutoimmunity Reviews, 2007
- Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: Suggested relationships with antigen-driven immune responsesJournal of Autoimmunity, 2007
- Cytokines in the pathogenesis of rheumatoid arthritisNature Reviews Immunology, 2007
- Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritisArthritis Research & Therapy, 2006
- Cytokine Pathways and Joint Inflammation in Rheumatoid ArthritisThe New England Journal of Medicine, 2001
- Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritisArthritis & Rheumatism, 2000
- T cell homeostasis in patients with rheumatoid arthritisProceedings of the National Academy of Sciences of the United States of America, 2000
- IL‐6 Is the Principal Factor Produced by Synovia of Patients with Rheumatoid Arthritis That Induces B‐Lymphocytes to Secrete ImmunoglobulinsAnnals of the New York Academy of Sciences, 1989